Volume 11 - Issue 3

Opinion Biomedical Science and Research Biomedical Science and Research CC by Creative Commons, CC-BY

The Activation of DNA Damage Response is the Basis of the Occurrence, Development and Resistance to Radioor Chemotherapy in Ovarian Cancer

*Corresponding author: Changsheng Peng, Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.

Received: December 13, 2020; Published: December 16, 2020

DOI: 10.34297/AJBSR.2020.11.001622

Opinion

Genome surveillance system is critical for eukaryotic cells to maintain genome stability [1,2]. Cell cycle checkpoints is quickly activated upon detecting various forms of DNA lesions, ensued by loading of repair factors to eliminate DNA damage [3]. ATM (Ataxia-Telangiectasia mutated) and ATR (ATM and Rad 3-related), the upstream checkpoint kinase, initiate damage detection and signal transduction after exposure to genotoxic insults including ionizing radiation or chemotherapeutic reagents [4]. To eliminate DNA lesions generated during genomic replication, ATR-dependent replication stress is activated to modulates the activities of the cell cycle regulator to halt cell cycle. In addition, ATR phosphorylates CHK1 to stall and thus maintain the integrity of replication fork, preventing catastrophe caused by fork collapse [5-6]. This is particularly important for the replication of fragile structures such as nucleolus-localized rDNA sequence. It is well known that ovarian cells have been exposed to high estrogen environment (some labs estimated the estrogen concentration in ovary is 100times higher than other tissues [7] for a long time, which greatly induces genomic instability and leads to ovarian cancer [8]. Our study found that compared with normal ovarian cells, the genome monitoring system of ovarian cancer cells still plays a role. Cancer cells rely on robust DNA damage response activation to survive the harsh environment´╝îsuch as genotoxicity-based radio- or chemotherapy. In addition, we also found that irradiating (IR) tumor cells with x-rays or adding chemotherapeutic drugs (cisplatin) could not only kill most ovarian tumor cells, but also promote tumor metastasis. Other laboratories have also reported that radiotherapy and chemotherapy may promote the metastasis of breast and prostate cancer by [9,10]. This is because radiotherapy and chemotherapy break the genetic stability of tumor cells and promote their epithelial-mesenchymal transformation. The effect of tumor metastasis was significantly weakened after we added ATM inhibitor (ATMi) or ATR inhibitor (siATR) to the cells.

Conclusion

In conclusion, we believe that radiotherapy and chemotherapy can promote ovarian cancer metastasis, there is hope to find the relevant Drug action targets, combined with radiotherapy and chemotherapy to completely kill tumor cells, which may be a good research idea.

Conflict of Interest

There is no conflict of interest.

References

Sign up for Newsletter

Sign up for our newsletter to receive the latest updates. We respect your privacy and will never share your email address with anyone else.